ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $31,000 | +34.8% | 6,470 | 0.0% | 0.03% | +31.8% |
| Q3 2014 | $23,000 | +21.1% | 6,470 | +56.3% | 0.02% | +37.5% |
| Q2 2014 | $19,000 | -5.0% | 4,140 | -1.2% | 0.02% | -5.9% |
| Q1 2014 | $20,000 | -4.8% | 4,190 | 0.0% | 0.02% | -5.6% |
| Q4 2013 | $21,000 | +10.5% | 4,190 | +35.6% | 0.02% | 0.0% |
| Q3 2013 | $19,000 | – | 3,090 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |